Assess and Learn
A Chronic Disease Approach to Obesity Management
This interactive video is designed for primary care clinicians looking to strengthen their approach to obesity management. It covers practical, evidence-based strategies for long-term pharmacotherapy — including how to select the right medications, prescribe safely, and individualize treatment for each patient. Before the activity begins, a brief knowledge assessment helps tailor the experience to your learning needs.
CME Information
Up to 0.75 AMA PRA Category 1 Credits, 0.75 ABIM MOC or 0.75 AANP, including 0.38 AANP Pharm
Release Date: 5/29/2026
Expiration Date: 5/29/2027
Topics
Recommended Based on Your Responses
Based on your responses to the pre-test, you will be directed to an educational activity that will best address the gaps in your knowledge. Upon completion of the activity, you will only be asked to respond to the post-test questions that were relevant to the education you received.
Learning Objectives
- Use a holistic, evidence-based approach to obesity management to formulate individualized treatment plans that support sustainable weight management
- Discuss the efficacy, safety, and best prescribing practices for long-term obesity medication
Faculty
Charles Vega, MD, FAAFP
Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, UC Irvine School of Medicine
Robert F. Kushner, MD, FACP
Professor of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
Disclosures
The following relevant financial relationships have been disclosed by those in a position to influence the content of this activity. All relevant relationships have been mitigated by Pri-Med Institute:
Charles Vega, MD, FAAFP: Consultant, Boehringer Ingelheim
Robert Kushner, MD, MS, DABOM: Advisor for Antag; Currax; Boehringer Ingelheim; Structure; Eli Lilly; Viking; AbbVie; AstraZeneca; Novo Nordisk
All others in control of content for this activity have disclosed no relevant financial relationships.
CME Information
AMA PRA Category 1 Credits
Accreditation Statement
Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement
Pri-Med Institute designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AANP
Accreditation Statement
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of Pri-Med Institute and Obesity Medicine Association. Pri-Med Institute is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider Number 040308.
Designation Statement
This activity is approved for 0.75 contact hour, which includes 0.38 hour of pharmacology.
MOC Credit Information
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Pri-Med Institute reports completion information to ACCME on a monthly basis, in the first week of each month.

Instructions for Obtaining Credit
Supported by
This activity is supported by an educational grant from Lilly.
Education Partners
Pri-Med Institute
Obesity Medicine Association